A five‑year‑old in Melbourne was diagnosed with Usher syndrome type 2A, a rare inherited condition that causes hearing loss and progressive vision loss. The diagnosis was confirmed by genetic testing in 2026, when the family learned the child’s hearing loss was linked to a specific genetic mutation. The condition is the leading cause of deafblindness in Australia and affects about 1 in 6,000 children.
Researchers at the Centre for Eye Research Australia (CERA) are working on a new RNA‑editing platform called EDITRA. The platform aims to fix the tiny spelling mistake in the faulty gene that causes vision loss, delivering the treatment to the eye in a single injection. The therapy is still in the laboratory stage but could, if successful, allow children with Usher syndrome 2A to preserve their sight.